Literature DB >> 29759429

Defining Blanking Period Post-Pulmonary Vein Antrum Isolation.

Pouria Alipour1, Zahra Azizi1, Meysam Pirbaglou2, Paul Ritvo2, Alfredo Pantano1, Atul Verma1, Yaariv Khaykin3.   

Abstract

OBJECTIVES: This study sought to determine the exact period after pulmonary vein antrum isolation (PVI) during which early recurrence of atrial tachyarrhythmia (ERAT) does not predict late arrhythmia recurrence (LR), in order to better define the blanking period.
BACKGROUND: Recurrence of atrial fibrillation after PVI is not uncommon. The first 3 months after PVI have been commonly treated as a blanking period, during which ERAT is not thought to predict LR after PVI; however, recent studies have shown that ERAT does predict LR.
METHODS: Baseline and follow-up data for 636 patients (mean age: 61.4 ± 10.6 years; 67.1% male; 59% paroxysmal atrial fibrillation; 31.4% ERAT) who underwent PVI between 2010 and 2014 were included. Recurrences were monitored by electrocardiography and Holter monitoring at 1-, 3-, 6-, 9-, and 12-month intervals post-procedure. Receiver-operating characteristic curve analysis was used to define the blanking period after PVI.
RESULTS: Overall, 51%, 76%, and 92% of patients who had ERAT in the first, second, and third month post-PVI, respectively, also experienced LR (p = 0.001). Using a logistic regression model, those manifesting ERAT during the first, second, and third month post-PVI were 4.22, 9.03, and 19.43 (p = 0.001) times more likely to experience LR, respectively, compared to those without ERAT. Furthermore, receiver-operating characteristic analysis revealed that 23 days post-PVI is the optimal cutoff date for the blanking period, with area under the curve of 0.7, sensitivity of 69.2%, and specificity of 61.2%.
CONCLUSIONS: The likelihood of experiencing LR progressively rises with ERAT after the first month post-PVI. Blanking period after PVI should be limited to the first 23 days clinically and in future studies.
Copyright © 2017 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  atrial fibrillation; blanking period; early recurrence; early recurrence of atrial tachyarrhythmia; late recurrence; pulmonary vein isolation

Mesh:

Year:  2017        PMID: 29759429     DOI: 10.1016/j.jacep.2017.01.006

Source DB:  PubMed          Journal:  JACC Clin Electrophysiol        ISSN: 2405-500X


  11 in total

1.  Clinical significance of the timing of early recurrence of atrial arrhythmia after pulmonary vein isolation: a two-institution clinical study.

Authors:  Yosuke Murase; Yasuya Inden; Hajime Imai; Seifuku Kyo; Satoshi Yanagisawa; Aya Fujii; Yusuke Sakamoto; Toshiro Tomomatsu; Toyoaki Murohara
Journal:  Heart Vessels       Date:  2018-11-02       Impact factor: 2.037

2.  Early Recurrences During the Blanking Period after Atrial Fibrillation Ablation.

Authors:  Jackson J Liang; Sanjay Dixit
Journal:  J Atr Fibrillation       Date:  2018-02-28

3.  Early recurrence during the blanking period and left atrial reverse remodeling after catheter ablation for non-paroxysmal atrial fibrillation.

Authors:  Takafumi Oka; Yasushi Koyama; Koji Tanaka; Yuko Hirao; Nobuaki Tanaka; Masato Okada; Issei Yoshimoto; Ryo Kitagaki; Atsunori Okamura; Katsuomi Iwakura; Yasushi Sakata; Kenshi Fujii; Koichi Inoue
Journal:  Int J Cardiol Heart Vasc       Date:  2020-07-23

4.  Adjunctive left anterior line ablation induced left atrial dysfunction and dyssynchrony in atrial fibrillation ablation.

Authors:  Hirosuke Yamaji; Takashi Murakami; Kazuyoshi Hina; Shunichi Higashiya; Hiroshi Kawamura; Masaaki Murakami; Shigeshi Kamikawa; Satoshi Hirohata; Shozo Kusachi
Journal:  Heart Vessels       Date:  2018-08-07       Impact factor: 2.037

5.  Bachmann bundle impairment following linear ablation of left anterior wall: impact on left atrial function.

Authors:  Yanjuan Zhang; Fengming Wu; Yu Gao; Nan Wu; Gang Yang; Mingfang Li; Lei Zhou; Di Xu; Minglong Chen
Journal:  Int J Cardiovasc Imaging       Date:  2021-09-27       Impact factor: 2.357

6.  The relationship of early recurrence of atrial fibrillation and the 3-month integrity of the ablation lesion set.

Authors:  Nebojša Mujović; Milan Marinković; Nebojša Marković; Vera Vučićević; Gregory Y H Lip; T Jared Bunch; Tatjana S Potpara
Journal:  Sci Rep       Date:  2018-06-29       Impact factor: 4.379

7.  Clinical significance of early recurrence of atrial fibrillation after cryoballoon vs. radiofrequency ablation-A propensity score matched analysis.

Authors:  Michifumi Tokuda; Seigo Yamashita; Seiichiro Matsuo; Mika Kato; Hidenori Sato; Hirotsuna Oseto; Eri Okajima; Hidetsugu Ikewaki; Masaaki Yokoyama; Ryota Isogai; Kenichi Tokutake; Kenichi Yokoyama; Ryohsuke Narui; Shin-Ichi Tanigawa; Michihiro Yoshimura; Teiichi Yamane
Journal:  PLoS One       Date:  2019-07-02       Impact factor: 3.240

8.  Noninvasive electrocardiography monitoring for very early recurrence predicts long-term outcome in patients after atrial fibrillation ablation.

Authors:  De-Yan Yang; Zhong-Wei Cheng; Yong-Tai Liu; Peng Gao; Tai-Bo Chen; Hua Deng; Kang-An Cheng; Jing-Bo Fan; Quan Fang
Journal:  Ann Noninvasive Electrocardiol       Date:  2020-06-25       Impact factor: 1.468

9.  Early arrhythmia recurrence after catheter ablation for persistent atrial fibrillation: is it predictive for late recurrence?

Authors:  Miruna A Popa; Marc Kottmaier; Elena Risse; Marta Telishevska; Sarah Lengauer; Katharina Wimbauer; Amir Brkic; Verena Kantenwein; Stephanie Ulrich; Marielouise Kornmayer; Hannah Krafft; Monika Hofmann; Susanne Kathan; Tilko Reents; Isabel Deisenhofer; Gabriele Hessling; Felix Bourier
Journal:  Clin Res Cardiol       Date:  2021-09-14       Impact factor: 5.460

10.  The predictive role of early recurrences of atrial arrhythmias after pulmonary vein cryoballoon ablation. Is blanking period an outdated concept? Insights from 12-month continuous cardiac monitoring.

Authors:  Karapet V Davtyan; Arpi H Topchyan; Hakob A Brutyan; Elena N Kalemberg; Maria S Kharlap; Georgiy Yu Simonyan; Andrey A Kalemberg; Maria V Kuznetsova
Journal:  BMC Cardiovasc Disord       Date:  2021-10-07       Impact factor: 2.298

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.